Bluejay Diagnostics, Inc.
BJDX
$1.56
-$0.0799-4.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.42% | -14.19% | -29.71% | -17.49% | -2.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.80% | -41.84% | -34.73% | -9.39% | -2.73% |
| Operating Income | 37.80% | 41.84% | 34.73% | 9.39% | 2.73% |
| Income Before Tax | 37.81% | 35.51% | 12.01% | 8.32% | 3.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 37.81% | 35.51% | 12.01% | 8.32% | 3.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.81% | 35.51% | 12.01% | 8.32% | 3.50% |
| EBIT | 37.80% | 41.84% | 34.73% | 9.39% | 2.73% |
| EBITDA | 38.04% | 35.64% | 29.19% | 5.91% | 2.41% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |